231 results
Page 2 of 12
8-K
vdy2q zxrd2njql
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.3
53kywz9b
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.1
eb9d17s
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
azgl51
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
EX-99.1
4lyu9631
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-4.2
u7z9fl8w i1noppj
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-4.1
djs7tomm
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-4.3
rzkxat1k9dk 1h
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
0uhatfb15x
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
ldohak
14 Aug 23
Business combination disclosure
4:16pm
425
EX-99.1
y7e10by
14 Aug 23
Business combination disclosure
4:16pm
8-K
wixonw9waltk p2f2vn
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
8-K
EX-99.1
q1616
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
425
pdzjn6uw0msg pmvs6
9 Aug 23
Business combination disclosure
4:02pm
425
EX-99.2
wtv1hdnboki
9 Aug 23
Business combination disclosure
4:02pm
425
EX-99.1
zush4gm0hc
9 Aug 23
Business combination disclosure
4:02pm
8-K
EX-99.2
iazpobj gfw5
9 Aug 23
Other Events
4:02pm
8-K
EX-99.1
31mkvk5 w88e3w2lucc
9 Aug 23
Other Events
4:02pm
8-K
62iopa34c9vu3 7eo7
9 Aug 23
Other Events
4:02pm